NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Research
Agency / Source: Altitude Marketing

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Copernicus Group IRB Chairperson, Glenn Veit Speaks at DIA - Veit presented perspectives of IRB process in Phase I Studies
Copernicus Group IRB Chairperson, Glenn Veit Speaks at DIA

 

NewswireTODAY - /newswire/ - Washington, DC, United States, 2010/08/12 - Veit presented perspectives of IRB process in Phase I Studies.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Copernicus Group IRB (CGIRB) Chairperson, Glenn Veit, spoke at the Drug Information Association 46th Annual Meeting. Along with colleagues from Duke University Medical Center and Pfizer, Inc., Mr. Veit presented a session titled "Three Perspectives of the IRB Process in Phase I Studies Conducted in an Academic Setting." The session focused on how obtaining Institutional Review Board (IRB) approval to conduct a Phase I clinical trial presents unique challenges for an academic site conducting the study, as well as the pharmaceutical sponsor, and the IRB.

"Having the opportunity to speak with Barry Mangum of Duke University Medical Center and Anne Cropp of Pfizer was professionally rewarding," said Veit. "Our session discussed three challenges ‐ operational, IRB approval process, and oversight ‐ through the lens of three stakeholders ‐ an academic site, the sponsor, and the IRB."

As the IRB representative for the session, Veit provided perspective by identifying the issues that make Phase I research at academic institutions different. He then explained how the IRB uses regulations and the principles of the Belmont Report to resolve those issues in a way that enhances subject safety and assists the sponsor and investigator in meeting goals for the research.

Veit summed up the session saying, "Hopefully the take‐away message is for people to better understand both the importance of IRB review and the potential benefits for all stakeholders."

About Glenn Veit
Veit has been with CGIRB since their first IRB review meeting in 1996. He is a graduate of Duke University and North Carolina Central University School of Law. Veit’s experience in all phases of the clinical trial process and areas of law make him an asset to Copernicus. Contact him at gveit[.]cgirb.com.

About Copernicus Group IRB
Experience and Innovation in Ethical Review™
Copernicus Group IRB (cgirb.com), established in July 1996, is a leading independent institutional review board ("IRB") dedicated to ensuring the rights and welfare of research study participants. The IRB provides ethical review of research protocols, investigators, and subject information and consent forms to ensure compliance with federal regulations set forth in 21 CFR, 45 CFR and ICH/GCP Guidelines. CGIRB achieved full AAHRPP accreditation in 2004 and ISO 9001:2008 certification in 2010.

Corporate Contact
Rebecca Sipes, CGIRB
One Triangle Drive, Suite 100
P.O. Box 110605
Research Triangle Park, NC 27709
E: rsipes[.]cgirb.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Altitude Marketing

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Research articles,
CATCH Visitors via Your Competitors Announcements!


Copernicus Group IRB Chairperson, Glenn Veit Speaks at DIA

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Gwen Hoover - AltitudeMarketing.com 
610-421-8601 gwen[.]altitudemarketing.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Altitude Marketing securities in any jurisdiction including any other companies listed or named in this release.

Research via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Altitude Marketing / Company Profile


Read Research Most Recent Related Newswires:

SCHOTT Receives Over €1.3 Million to Advance Nuclear Fusion Research
NASA’s Jet Propulsion Laboratory Enhances Public Safety with CentralSquare Technologies’ Pro Suite
BASF to Research on Alternatives to Animal Testing on Behalf of the European Chemicals Agency (ECHA)
NEC Joins Columbia University-led National Science Foundation Engineering Research Center for Smart Streetscapes (CS3)
Tractebel to Conduct Feasibility Study for Iconic Einstein Telescope
Parexel Recognized with Frost & Sullivan’s 2023 North American Customer Value Leadership Award for Impactful Real-world Evidence Solutions
ABB and Imperial College Extend Carbon Capture Collaboration to Support Future Workforce and Energy Transition
ANDRITZ Opens The Food Innovation Xperience Test Center
Emulate Earns Frost & Sullivan’s 2023 Technology Innovation Leadership Award
CEA and Siemens Collaborate on Research to Expand Applications of Digital Twin for Industry
Innovative Research for Malaria Control Driven by Three Collaborating Parties - Swiss TPH, BASF and Promega
Aichi Cancer Center and NEC Develop an Efficient Method for Identifying Lung Cancer Antigens and Antigen-Specific T Cells
Thales Alenia Space Will be Part of the Consortium to Develop the Destination Earth Core Service Platform
Transgene and NEC Present New Data on TG4050, an Individualized Cancer Vaccine At ASCO 2023
State of Indiana, Purdue University and Imec Announce MOU on Research and Development Partnership Powering State’s Semiconductor Ecosystem Growth

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2005-2024 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)